BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 24315827)

  • 21. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.
    MacDonald K; Porter GA; Guernsey DL; Zhao R; Casson AG
    Cancer Epidemiol; 2009 Jul; 33(1):37-40. PubMed ID: 19679045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.
    Gall A; Fero J; McCoy C; Claywell BC; Sanchez CA; Blount PL; Li X; Vaughan TL; Matsen FA; Reid BJ; Salama NR
    PLoS One; 2015; 10(6):e0129055. PubMed ID: 26076489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.
    Di Martino E; Wild CP; Rotimi O; Darnton JS; Olliver RJ; Hardie LJ
    Biomarkers; 2006; 11(6):547-61. PubMed ID: 17056474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
    Duggan C; Onstad L; Hardikar S; Blount PL; Reid BJ; Vaughan TL
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):934-43. PubMed ID: 23466711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.
    Peng DF; Hu TL; Soutto M; Belkhiri A; El-Rifai W
    Carcinogenesis; 2014 Jul; 35(7):1620-8. PubMed ID: 24692067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
    Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
    Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
    Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.
    Ii M; Li H; Adachi Y; Yamamoto H; Ohashi H; Taniguchi H; Arimura Y; Carbone DP; Imai K; Shinomura Y
    Clin Cancer Res; 2011 Aug; 17(15):5048-59. PubMed ID: 21642381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.
    Wang Y; Adachi Y; Imsumran A; Yamamoto H; Piao W; Li H; Ii M; Arimura Y; Park MY; Kim D; Lee CT; Carbone DP; Imai K; Shinomura Y
    J Gastroenterol; 2010 Feb; 45(2):159-70. PubMed ID: 19902140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
    White BD; Chien AJ; Dawson DW
    Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Obesity Associated with Barrett's Esophagus and Esophageal Adenocarcinoma?
    Lynch KL
    Gastroenterol Clin North Am; 2016 Dec; 45(4):615-624. PubMed ID: 27837776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
    Kwon J; Stephan S; Mukhopadhyay A; Muders MH; Dutta SK; Lau JS; Mukhopadhyay D
    Cancer Res; 2009 Feb; 69(4):1350-7. PubMed ID: 19190347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol and gastrointestinal cancers.
    Vanella G; Archibugi L; Stigliano S; Capurso G
    Curr Opin Gastroenterol; 2019 Mar; 35(2):107-113. PubMed ID: 30550381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer.
    Heo JW; Kim SE; Sung MK
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.